The issue of statin safety: where do we stand?
Grundy
Scott M
SM
D056486:Chemical and Drug Induced Liver Injury; D017277:Drug Approval; D005464:Fluorobenzenes / Q000633:toxicity; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000592:standards / Q000633:toxicity*; D007674:Kidney Diseases / Q000139:chemically induced; D008077:Lipoproteins, LDL / Q000097:blood; D011725:Pyridines / Q000633:toxicity; D011743:Pyrimidines / Q000633:toxicity; D018570:Risk Assessment; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000633:toxicity; D016896:Treatment Outcome
D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008077:Lipoproteins, LDL; D011725:Pyridines; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium; C086276:cerivastatin